tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Latest News

SPYR Launches Worldwide Update of Pocket Starships with Hivespawn Expansion & Marketing Campaign

SPYR Launches Worldwide Update of Pocket Starships with Hivespawn Expansion & Marketing Campaign

Written by Ι Stock Market Media — September 8, 2016

This week SPYR, Inc. (OTCQB: SPYR) released a major content update (patch) for its flagship MMO game Pocket Starships. With this update, SPYR will launch its much-anticipated marketing and advertising campaign that should drive new gamers to SPYR’s real-time cross-platform game. This content update and the marketing campaign that will accompany it, mark the “official” worldwide launch of Pocket Starships.

As we have seen with the recent release of Pokémon Go, getting the word ...

Read More →
0

Pocket Starships Could Unite eSports and Mobile eSports Gamers

Pocket Starships Could Unite eSports and Mobile eSports Gamers

Written by Ι Stock Market Media — July 19, 2016

Worldwide the number of gamers who use mobile devices to play their favorite digital games is mind-boggling. So much so that some have called today’s gamers the “touchscreen generation.” SPYR, Inc. (OTCQB: SPYR) understands the trend is swinging heavily in favor of smartphones and tablets as the go-to devices that gamers are choosing, and SPYR also realizes that hardcore PC and console gamers aren’t ready to give up their choice for gaming either. ...

Read More →
0

As Diabetes Becomes Global Epidemic, PharmaCyte Biotech’s Insulin Producing Cells Receive 20 Years of Protection

As Diabetes Becomes Global Epidemic, PharmaCyte Biotech’s Insulin Producing Cells Receive 20 Years of Protection

Written by Ι Stock Market Media — July 19, 2016

Worldwide the number of people living with diabetes has reached 422 million, and if the current trend continues, over 700 million people are expected to be living with diabetes by 2025. Diabetes has clearly become a healthcare crisis on a global scale, and PharmaCyte Biotech (OTCQB: PMCB) recently received some good news in the form of patent protection that will help the company do its part in bringing a treatment to tens of ...

Read More →
0

Pocket Starships Could be SPYR’s Ticket to Growing Revenues in a Fast-Growing Digital Games Market

Pocket Starships Could be SPYR’s Ticket to Growing Revenues in a Fast-Growing Digital Games Market

Written by Ι Stock Market Media — May 26, 2016

When SPYR, Inc. (OTCQB: SPYR) moved into the mobile game & app development and publishing industry, a decision was made early on to surround the company with successful industry names, and to partner with reputable third-party developers to publish quality mobile games. Well, the company has done both, and its recent agreement to publish the free-to-play Massively Multiplayer Online Game or MMO, Pocket Starships, may just lead to the game becoming SPYR’s “diamond ...

Read More →
0

SPYR’s Paul Thind Discusses Company’s Future in Mobile Games Industry

SPYR’s Paul Thind Discusses Company’s Future in Mobile Games Industry

Written by Ι Stock Market Media — March 2, 2016

SPYR, Inc. (OTCQB: SPYR) has been busy in the mobile game & app development and publishing industry since it entered the space almost a year ago. With plenty of news already coming from the Denver tech firm in 2016, Stock Market Media Group (SMMG), a research and content development investment relations firm, caught up with Paul Thind, SPYR’s Managing Director of Games & Applications, while he attended the Casual Connect conference in Amsterdam, ...

Read More →
0

Johnson & Johnson and Big Pharma Could Find a Diabetes “Cure” with PharmaCyte Biotech’s Type 1 Diabetes Treatment

Johnson & Johnson and Big Pharma Could Find a Diabetes “Cure” with PharmaCyte Biotech’s Type 1 Diabetes Treatment

Written by Ι Stock Market Media — February 8, 2016

Johnson & Johnson, like much of the biopharmaceutical industry worldwide, is aware of the desperate necessity for a Type 1 diabetes treatment. In fact, Diego Miralles, Johnson & Johnson’s head of global innovation, said that his company’s recent decision to partner with a privately held San Diego biotech was to “hedge our bets to make sure we would win in this space.” Johnson & Johnson’s deal with ViaCyte, Inc. is an effort to ...

Read More →
0
Page 5 of 31 «...34567...»
ContactUs.com ContactUs.com